Borosil Scientific share price & results
- Jun 2026
- Sept 2026
Borosil-brand maker of lab glassware, equipment, process reactors and pharma glass ampoules/vials in India.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 99.9 | +12.2% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 11.1 | +1.1 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 6.8 | +1387.0% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
| Return on equity | 10.45 | +2.8 pts | Trailing twelve months | TTM to Jun 2026 | Adjusted profit attributable to owners ÷ average owners’ equity. |
| Free cash flow margin | 3.35 | −21.1 pts | Fiscal year | FY ending Mar 2026 | (Operating cash flow − fixed-asset purchases + disposals) ÷ revenue. |
| Revenue growth (YoY) | 11.22 | −4.3 pts | Trailing twelve months | TTM to Jun 2026 | Revenue change against the same period one year earlier. |
Price
Performance −21.2% 1Y
1Y: ₹135.35 on 24 Oct 2025 → ₹106.65. High ₹173.52 (30 Jun 2026), low ₹100.97 (27 Mar 2026).
- Previous close
- ₹105.8
- Market cap
- ₹941 Cr
- 52-week range
- ₹100.97 – ₹173.52
- One year
- −21.94%
- Price to earnings (TTM to Jun 2026)
- 21.32×
- Return on equity (TTM to Jun 2026)
- 10.45%
Overview
- Symbol
- NSE:BOROSCI
- Sector
- Capital Goods
- Industry
- Industrials
- Exchange
- NSE
- Currency
- INR
What Borosil Scientific Limited does
Based on the company's own presentations, annual report and earnings calls.
Borosil Scientific Limited manufactures laboratory glassware and consumables, laboratory instruments (under the LabQuest brand), process-science equipment such as reactors (via subsidiary Goel Scientific Glass Works), and pharmaceutical primary packaging in the form of glass ampoules and tubular glass vials sold to injectable-drug makers. It also produces borosilicate domestic glassware (serveware, drinkware and storage) under the Borosil name. The company was demerged from Borosil Ltd in December 2023 and listed separately in June 2024, though its laboratory-glassware operations trace back to Borosil's 1962 founding as India's pioneer of borosilicate glassware. It earns revenue selling these products to research institutes, pharmaceutical companies, industrial labs and academia across India and in 90+ export countries, distributed through a channel-partner and warehouse network.
Segments
- Scientific Segment
- Glassware Segment
- Manufacturing facilities
- 4 plants: Bharuch (Gujarat, laboratory glassware), Pune (Maharashtra, lab equipment/instrumentation), Nashik (Maharashtra, pharma primary packaging), Vadodara (Gujarat, process equipment via Goel Scientific)
- Employees
- 1,800+ colleagues
- Channel partners
- 150+ across India
- Warehouses
- 4 PAN-India (Bharuch mother warehouse plus North, East and South regional warehouses)
- Export footprint
- 90+ countries
- Product portfolio
- 4,000+ SKUs spanning laboratory glassware/consumables, lab equipment, process systems and pharma primary packaging
Fundamentals
Ratios, each with its period
Current values with the period they cover; the trend reads across the 3 fiscal years held (Mar 2024 to Mar 2026).
Financials
What the filings say
Net profit, year on year: +1387% (quarter to jun 2026 against jun 2025).
| Line item | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 87 | 94 | 118 | 89 | 99 | 107 | 132 | 100 |
| Expenses | 74 | 82 | 96 | 80 | 87 | 89 | 101 | 89 |
| Operating profit | 14 | 12 | 21 | 9 | 12 | 18 | 31 | 11 |
| Operating margin | 15.6% | 12.7% | 18.1% | 9.9% | 12.3% | 16.6% | 23.6% | 11.1% |
| Other income | 2 | 2 | 3 | -4 | 2 | 1 | 2 | 3 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Profit before tax | 11 | 9 | 20 | 1 | 10 | 14 | 29 | 9 |
| Tax rate | 28.9% | 28.3% | 27.4% | 30.3% | 25.8% | 27.6% | 25.4% | 26.4% |
| Net profit | 8 | 7 | 14 | 0 | 8 | 10 | 22 | 7 |
| EPS (₹ per share) | 0.87 | 0.75 | 1.59 | 0.05 | 0.85 | 1.15 | 2.42 | 0.77 |
| Line item | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Sales | 355 | 392 | 428 |
| Expenses | 304 | 334 | 358 |
| Operating profit | 51 | 58 | 70 |
| Other income | 5 | 8 | 2 |
| Interest | 1 | 1 | 0 |
| Depreciation | 15 | 17 | 18 |
| Profit before tax | 40 | 48 | 54 |
| Net profit | 31 | 35 | 40 |
| Line item | Mar 2023 | Mar 2024 | Mar 2025 | Sept 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity capital | 0 | 9 | 9 | 9 | 9 |
| Reserves | 352 | 374 | 411 | 396 | 453 |
| Borrowings | 11 | 11 | 6 | 9 | 1 |
| Other liabilities | 69 | 82 | 74 | 89 | 87 |
| Total liabilities | 432 | 477 | 499 | 502 | 549 |
| Fixed assets | 150 | 159 | 155 | 185 | 156 |
| Capital work in progress | 8 | 1 | 1 | 2 | 9 |
| Investments | 32 | 41 | 146 | 108 | 175 |
| Other assets | 241 | 275 | 197 | 207 | 209 |
| Total assets | 432 | 477 | 499 | 502 | 549 |
| Line item | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Cash from operations | 32 | 127 | 50 |
| Cash from investing | -20 | -121 | -47 |
| Cash from financing | -1 | -5 | -4 |
| Net cash flow | 11 | 1 | -1 |
| Free cash flow | 20 | 114 | 25 |
| Line item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Debtor days | 46 | 54 | 60 | 62 |
| Inventory days | 325 | 256 | 227 | 232 |
| Days payable | 70 | 102 | 79 | 98 |
| Cash conversion cycle | 301 | 208 | 207 | 196 |
| Working capital days | 190 | 181 | 96 | 92 |
| Return on capital employed | — | 11.0% | 12.0% | 14.0% |
| Dividend payout | 0.0% | 0.0% | 0.0% | 0.0% |
Where revenue comes from
The businesses behind the company’s reported revenue.
Scientific – Laboratory Glass & equipment and Process System contributes 62.5% of reported segment revenue.
Quarter ended 30 Jun 2026 · Consolidated
- Scientific – Laboratory Glass & equipment and Process System 62.5%
₹66.68 crore
- Glassware 35.9%
₹38.36 crore
- Others 1.6%
₹1.71 crore
| Business segment | Revenue · ₹ crore | Share |
|---|---|---|
| Scientific – Laboratory Glass & equipment and Process System | 66.68 | 62.5% |
| Glassware | 38.36 | 35.9% |
| Others | 1.71 | 1.6% |
Share = segment revenue ÷ total segment revenue, before intersegment adjustments.
How these numbers add up
- Total segment revenue
- ₹106.75 crore
- Intersegment adjustment
- ₹0.00 crore
- Net segment revenue
- ₹106.75 crore
Intersegment transactions are between the company’s own businesses. Net segment revenue can differ from income-statement revenue because reporting definitions differ.
Source: FinEdge · Last checked 19 Sept 2026. Reported segment names are kept as supplied.
How the mix has moved
Glassware grew from 32% to 36% of revenue over the last two years.
| Segment | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | YoY growth latest quarter |
|---|---|---|---|---|---|---|---|---|---|
| Scientific – Laboratory Glass & equipment and Process System | — | 69% | — | — | — | — | — | 62% | — |
| Glassware | 32% | 30% | 23% | 34% | 32% | 27% | 22% | 36% | +19.0% |
| Others | 1% | 1% | 1% | 1% | 2% | 1% | 1% | 2% | +175.6% |
Share of reported segment revenue by quarter, consolidated basis, as filed. A quarter the company did not report is left blank, never carried forward.
See how segments are shifting across companies → Segment Shift
What the price assumes
FairTo justify its price of ₹107, this stock must grow earnings at 14% every year for 7 years. Our analysis caps realistic growth at ~13%. At that growth it is worth ₹101 — downside of 5%.
- Growth the price implies
- 14.5% a year
- for 7 years, fading to 4%
- It has actually compounded at
- 12.4% a year
- net profit, FY24–FY26 · EPS 13.5%
- The gap
- 0.0 pp
- -5% downside if it only repeats history
Ownership
Who owns it
Promoters hold 68.27% as of Sept 2026; institutions cut 0.08 pts since Jun 2026.
- Promoters 68.27%
- Foreign institutions 0.14%
- Domestic institutions 0.27%
- Public 31.30%
Who is on the register
Named in the Sep 2026 filing
Every holder of Borosil Scientific Limited above SEBI's 1% disclosure line, and what changed since Jun 2026.
| Holder | Stake | Change |
|---|---|---|
| 25.52% | unchanged | |
| 13.85% | unchanged | |
| 11.16% | unchanged | |
| 11.03% | unchanged | |
| 2.64% | unchanged | |
| 2.18% | unchanged | |
| 2.17% | unchanged | |
| 2.11% | unchanged | |
| 1.10% | unchanged | |
| 0.97% | unchanged | |
| 0.77% | unchanged | |
| 0.20% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Your own record
Start an Inve Case for Borosil Scientific Limited
Free account: one company. Everything above stays public.
Write why you follow Borosil Scientific Limited and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading
Other Capital Goods companies
Learn to analyse Borosil Scientific Limited
Guides on how to read this kind of business and the numbers that matter.